Funding for this research was provided by:
Cystic Fibrosis Foundation
National Center for Advancing Translational Sciences ((UL1-TR002494))
McKnight Land-Grant Professorship
Chainbreaker Breakthrough Cancer Research Grant from the Masonic Cancer Center,University of Minnesota
Minnesota Partnership for Biotechnology and Medical Genomics
Chainbreaker Breakthrough Cancer Research Grant from the Masonic Cancer Center at the University of Minnesota
Doctoral Dissertation Fellowship, University of Minnesota
Text and Data Mining valid from 2020-01-28
Received: 13 November 2019
Accepted: 5 January 2020
First Online: 28 January 2020
Ethics approval and consent to participate
: This study was approved by the University of Minnesota Institutional Review Board (IRB protocol 1408 M52889), and written informed consent was obtained from all individuals involved in this study. The research was performed in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.